Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €110.00 EUR
Change Today +2.66 / 2.48%
Volume 150.1K
WCH On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 3:35 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

wacker chemie ag (WCH) Snapshot

Open
€107.37
Previous Close
€107.34
Day High
€111.70
Day Low
€107.20
52 Week High
03/6/15 - €111.70
52 Week Low
05/19/14 - €76.04
Market Cap
5.7B
Average Volume 10 Days
93.8K
EPS TTM
€3.74
Shares Outstanding
52.2M
EX-Date
05/16/14
P/E TM
29.4x
Dividend
€0.50
Dividend Yield
0.45%
Current Stock Chart for WACKER CHEMIE AG (WCH)

Related News

No related news articles were found.

wacker chemie ag (WCH) Related Businessweek News

No Related Businessweek News Found

wacker chemie ag (WCH) Details

Wacker Chemie AG provides specialty chemical products worldwide. It operates through five divisions: WACKER SILICONES, WACKER POLYMERS, WACKER BIOSOLUTIONS, WACKER POLYSILICON, and Siltronic. The WACKER SILICONES division offers a portfolio of approximately 2,800 products ranging from silicone fluids and emulsions, resins, elastomers, and sealants, to silanes and pyrogenic silica grades, which are used as starting materials in the production of silicones. The WACKER POLYMERS division manufactures binders and polymeric additives, such as dispersible polymer powders and dispersions used in various industrial applications, or as base chemicals in paints, coatings, paper, and adhesives industries, as well as in the construction industry. The WACKER BIOSOLUTIONS division supplies customized biotech and catalog products for fine chemical sector, including pharmaceutical proteins, cyclodextrins, cysteine, polyvinyl acetate solid resins, organic intermediates, and acetylacetone. This division focuses on customer-specific solutions in the areas of food additives, pharmaceutical actives, and agrochemicals. The WACKER POLYSILICON division produces hyperpure polysilicon for the semiconductor, electronics, and solar sectors. The Siltronic division supplies silicon wafers for various semiconductor manufacturers that are used as raw materials for various semiconductor products, including discrete semiconductor components or microchips. The company was founded in 1914 and is headquartered in Munich, Germany.

16,724 Employees
Last Reported Date: 10/30/14
Founded in 1914

wacker chemie ag (WCH) Top Compensated Officers

Chief Executive Officer, President and Member...
Total Annual Compensation: €1.4M
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €1.1M
Member of Executive Board
Total Annual Compensation: €1.1M
Member of the Executive Board
Total Annual Compensation: €682.3K
Compensation as of Fiscal Year 2013.

wacker chemie ag (WCH) Key Developments

Wacker Chemie Building Specialty Monomers Plant

Wacker Chemie is building a new 3,800 tonne/year specialty monomers plant at its Burghausen site. The group has budgeted around €8 million for the construction. The plant, which will produce specialty monomers vinyl neodecanoate and vinyl laurate - raw materials for the manufacture of specific dispersible polymer powders, is scheduled for start-up in the second quarter of 2015.

Andreas Biagosch Joins Wacker's Supervisory Board

Dr. Andreas H. Biagosch (59) has joined Wacker Chemie AG's Supervisory Board. He succeeds Dr. Bernd W. Voss, who has stepped down for health reasons. Since 2013, Biagosch has been Managing Director at Impacting I GmbH & Co.KG  and Impact GmbH (consulting and investment firms).

WACKER Group Opens New Health Center at Burghausen Site

WACKER Group has announced the opening of a new health center at its Burghausen site. Equipped with medical technology, the Center will provide flexible health care to the site's approximately 10,000 employees. WACKER invested around EUR 4 million in the new building.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WCH:GR €110.00 EUR +2.66

WCH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €70.97 EUR +1.07
Celanese Corp $57.62 USD -0.85
Clariant AG SFr.17.49 CHF +0.05
K+S AG €28.59 EUR -0.145
Lonza Group AG SFr.123.10 CHF -0.80
View Industry Companies
 

Industry Analysis

WCH

Industry Average

Valuation WCH Industry Range
Price/Earnings 24.1x
Price/Sales 1.0x
Price/Book 2.3x
Price/Cash Flow 25.3x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WACKER CHEMIE AG, please visit www.wacker.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.